BACKGROUND: Lymphocytes contribute to ischemia/reperfusion (I/R) injury in several organ systems, but their relevance in ST elevation myocardial infarction (STEMI) is unknown. Our goal was to characterize lymphocyte dynamics in individuals after primary percutaneous coronary intervention (PPCI), assess the prognostic relevance of these cells, and explore mechanisms of lymphocyte-associated injury. METHODS: Lymphocyte counts were retrospectively analyzed in 1,377 STEMI patients, and the prognostic relevance of post-PPCI lymphopenia was assessed by Cox proportional hazards regression. Blood from 59 prospectively recruited STEMI patients undergoing PPCI was sampled, and leukocyte subpopulations were quantified. Microvascular obstruction (MVO), a component of I/R injury, was assessed using MRI. RESULTS: In the retrospective cohort, lymphopenia was associated with a lower rate of survival at 3 years (82.8% vs. 96.3%, lowest vs. highest tertile; hazard ratio 2.42). In the prospective cohort, lymphocyte counts fell 90 minutes after reperfusion, primarily due to loss of T cells. CD8+ T cells decreased more than CD4+ T cells, and effector subsets exhibited the largest decline. The early decrease in effector T cell levels was greater in individuals that developed substantial MVO. The drop in T cell subsets correlated with expression of the fractalkine receptor CX3CR1 (r2 = 0.99, P = 0.006). Serum fractalkine concentration peaked at 90 minutes after reperfusion, coinciding with the T cell count nadir. CONCLUSIONS: Lymphopenia following PPCI is associated with poor prognosis. Our data suggest that fractalkine contributes to lymphocyte shifts, which may influence development of MVO through the action of effector T cells. TRIAL REGISTRATION: Not applicable. FUNDING: British Heart Foundation (FS/12/31/29533) and National Institute of Health Research (NIHR) Newcastle Biomedical Research Centre.
BACKGROUND: Lymphocytes contribute to ischemia/reperfusion (I/R) injury in several organ systems, but their relevance in ST elevation myocardial infarction (STEMI) is unknown. Our goal was to characterize lymphocyte dynamics in individuals after primary percutaneous coronary intervention (PPCI), assess the prognostic relevance of these cells, and explore mechanisms of lymphocyte-associated injury. METHODS: Lymphocyte counts were retrospectively analyzed in 1,377 STEMI patients, and the prognostic relevance of post-PPCI lymphopenia was assessed by Cox proportional hazards regression. Blood from 59 prospectively recruited STEMI patients undergoing PPCI was sampled, and leukocyte subpopulations were quantified. Microvascular obstruction (MVO), a component of I/R injury, was assessed using MRI. RESULTS: In the retrospective cohort, lymphopenia was associated with a lower rate of survival at 3 years (82.8% vs. 96.3%, lowest vs. highest tertile; hazard ratio 2.42). In the prospective cohort, lymphocyte counts fell 90 minutes after reperfusion, primarily due to loss of T cells. CD8+ T cells decreased more than CD4+ T cells, and effector subsets exhibited the largest decline. The early decrease in effector T cell levels was greater in individuals that developed substantial MVO. The drop in T cell subsets correlated with expression of the fractalkine receptor CX3CR1 (r2 = 0.99, P = 0.006). Serum fractalkine concentration peaked at 90 minutes after reperfusion, coinciding with the T cell count nadir. CONCLUSIONS:Lymphopenia following PPCI is associated with poor prognosis. Our data suggest that fractalkine contributes to lymphocyte shifts, which may influence development of MVO through the action of effector T cells. TRIAL REGISTRATION: Not applicable. FUNDING: British Heart Foundation (FS/12/31/29533) and National Institute of Health Research (NIHR) Newcastle Biomedical Research Centre.
Authors: Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein Journal: J Am Coll Cardiol Date: 2005-04-25 Impact factor: 24.094
Authors: Stoyan Dimitrov; Christian Benedict; Dennis Heutling; Jürgen Westermann; Jan Born; Tanja Lange Journal: Blood Date: 2009-03-17 Impact factor: 22.113
Authors: Zequan Yang; Yuan-Ji Day; Marie-Claire Toufektsian; Yaqin Xu; Susan I Ramos; Melissa A Marshall; Brent A French; Joel Linden Journal: Circulation Date: 2006-10-23 Impact factor: 29.690
Authors: Alparslan Kurtul; Mikail Yarlioglues; Sani Namik Murat; Gokhan Ergun; Mustafa Duran; Haci Ahmet Kasapkara; Muhammed Bora Demircelik; Mustafa Cetin; Adil Hakan Ocek Journal: Am J Cardiol Date: 2014-05-15 Impact factor: 2.778
Authors: Vicente Bodí; Juan Sanchis; Julio Núñez; Eva Rumiza; Luis Mainar; María P López-Lereu; José V Monmeneu; Ricardo Oltra; María J Forteza; Francisco J Chorro; Angel Llácer Journal: Rev Esp Cardiol Date: 2009-10 Impact factor: 4.753
Authors: A Phillip Owens; Nathan Robbins; Keith Saum; Shannon M Jones; Akiva Kirschner; Jessica G Woo; Connie McCoy; Samuel Slone; Marc E Rothenberg; Elaine M Urbina; Michael Tranter; Jack Rubinstein Journal: Am J Physiol Heart Circ Physiol Date: 2018-09-14 Impact factor: 4.733
Authors: Max Rieckmann; Murilo Delgobo; Chiara Gaal; Lotte Büchner; Philipp Steinau; Dan Reshef; Cristina Gil-Cruz; Ellis N Ter Horst; Malte Kircher; Theresa Reiter; Katrin G Heinze; Hans Wm Niessen; Paul Aj Krijnen; Anja M van der Laan; Jan J Piek; Charlotte Koch; Hans-Jürgen Wester; Constantin Lapa; Wolfgang R Bauer; Burkhard Ludewig; Nir Friedman; Stefan Frantz; Ulrich Hofmann; Gustavo Campos Ramos Journal: J Clin Invest Date: 2019-08-13 Impact factor: 14.808
Authors: Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy Journal: Cardiovasc Res Date: 2019-06-01 Impact factor: 10.787
Authors: Gustavo Campos Ramos; Anne van den Berg; Vânia Nunes-Silva; Johannes Weirather; Laura Peters; Matthias Burkard; Mike Friedrich; Jürgen Pinnecker; Marco Abeßer; Katrin G Heinze; Kai Schuh; Niklas Beyersdorf; Thomas Kerkau; Jocelyne Demengeot; Stefan Frantz; Ulrich Hofmann Journal: Proc Natl Acad Sci U S A Date: 2017-03-02 Impact factor: 11.205
Authors: Bonnie Chen; Stephen R Morris; Soumya Panigrahi; Gillian M Michaelson; Jonathan M Wyrick; Alexey A Komissarov; Daria Potashnikova; Anna Lebedeva; Souheil-Antoine Younes; Karem Harth; Vikram S Kashyap; Elena Vasilieva; Leonid Margolis; David A Zidar; Scott F Sieg; Carey L Shive; Nicholas T Funderburg; Sara Gianella; Michael M Lederman; Michael L Freeman Journal: J Immunol Date: 2020-03-30 Impact factor: 5.422